Daily News
May 18 2013
United States - US Senate passes renewable chemicals funding under Farm Bill
The US Senate Agriculture Committee on May 15 passed a bill under the federal Farm Bill including mandatory funding for energy title programs and eligibility for renewable chemicals in Farm Bill reauthorisation legislation.
Read Article >>International - OPXBIO and Evonik ink agreement for renewable specialty chemicals
Evonik of Germany and US-based OPX Biotechnologies in mid-May entered into an agreement to jointly develop a list of undisclosed renewable specialty chemicals.
Read Article >>Brazil - BNDES and Finep to spend more on next generation biofuel research
BNDES, Brazil’s national development bank, and its research-financing agency Finep have approved BRL2.2 bln ($1=BRL2.008) of projects for research into new sugar-cane processing technologies this year and may approve another BRL400 mln, Artur Yabe, Manager of the BNDES' Biofuels Department told Bloomberg. The state-owned organizations may also start evaluating another BRL800 mln of projects by the end of the year.
Read Article >>International - BASF to produce renewable BDO with Genomatica process
Chemical major BASF of Germany in mid-May said it would begin production of renewable 1,4-butanediol (BDO) using US-based Genomatica's one-step fermentation process.
Read Article >>
Filter news by category
Follow Us
More News
United States - Gevo temporarily dismisses lawsuit against Butamax
United States - Solazyme and AkzoNobel enter JDA on surfactants, coatings
United States - Metabolix's Q1 2013 results show weak start into the new year
United States - BioAmber raises $80 mln in IPO after slashing price by 38%
United States - Codexis' Q1 revenue falls sharply on termination of Shell agreement
United States - Solazyme's Q1 2013 revenues slip on loss of government funding
Isobutanol: first chemicals, then fuels
United States - Q1 PLA exports hit lowest in three years
France - Solvay invests in polyamide production unit in Lyon
United States - Gevo's Q1 loss improves slightly despite lack of sales
United States - Amyris' Q1 results show signs of improvement
